Efficacy and Safety of Melflufen Plus Daratumumab and Dexamethasone in Relapsed/refractory Multiple Myeloma: Results from the Randomized, Open-Label, Phase III LIGHTHOUSE Study.
Haematologica（2024）
关键词
International Myeloma Working Group
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要